By expenditures
| Name | Title | Type |
|---|---|---|
| Dominic Accurso | Controller | Auditee |
| Steve Marriott | CONTROLLER | Auditee |
| Kristen Hughes | Managing Director | Auditee |
| Clarkson Hanner | Audit Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 388434 | 2025 | 2026-02-21 | RSM US LLP | $21.71M |
| 331386 | 2024 | 2024-12-09 | Rsm US LLP | $33.04M |
| 6155 | 2023 | 2023-12-11 | Rsm US LLP | $28.29M |
| 30232 | 2022 | 2023-01-19 | Marr and Company PC | $38.42M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 388434 | 2025 | 2026-02-21 | 1174867 | 2025-004 | Material Weakness | Yes | F |
| 388434 | 2025 | 2026-02-21 | 1174866 | 2025-004 | Material Weakness | Yes | F |
| 388434 | 2025 | 2026-02-21 | 1174865 | 2025-004 | Material Weakness | Yes | F |
| 388434 | 2025 | 2026-02-21 | 1174864 | 2025-003 | Material Weakness | Yes | P |
| 388434 | 2025 | 2026-02-21 | 1174863 | 2025-003 | Material Weakness | Yes | P |
| 388434 | 2025 | 2026-02-21 | 1174862 | 2025-003 | Material Weakness | Yes | P |
| 331386 | 2024 | 2024-12-09 | 1089990 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 1089989 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089988 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 1089987 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 1089986 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089985 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 1089984 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 1089983 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089982 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 1089981 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 1089980 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089979 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 1089978 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089977 | 2024-003 | Material Weakness | - | I |
| 331386 | 2024 | 2024-12-09 | 1089976 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089975 | 2024-003 | Material Weakness | - | I |
| 331386 | 2024 | 2024-12-09 | 1089974 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 1089973 | 2024-003 | Material Weakness | - | I |
| 331386 | 2024 | 2024-12-09 | 513548 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 513547 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513546 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 513545 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 513544 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513543 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 513542 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 513541 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513540 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 513539 | 2024-006 | - | - | F |
| 331386 | 2024 | 2024-12-09 | 513538 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513537 | 2024-004 | Material Weakness | - | F |
| 331386 | 2024 | 2024-12-09 | 513536 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513535 | 2024-003 | Material Weakness | - | I |
| 331386 | 2024 | 2024-12-09 | 513534 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513533 | 2024-003 | Material Weakness | - | I |
| 331386 | 2024 | 2024-12-09 | 513532 | 2024-005 | Significant Deficiency | - | L |
| 331386 | 2024 | 2024-12-09 | 513531 | 2024-003 | Material Weakness | - | I |